The physician's responsibility under the new medicare reimbursement for hospice care

H. Brody, J. Lynn

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

New legislation to provide Medicare reimbursement for hospice care has created problems for physicians who are involved in the treatment of the terminally ill. Under current proposals, hospice services will be reimbursed by a certain amount per patient-day, according to four categories of level of care, and for a maximum of 210 days. At 210 days, reimbursement will cease, but the hospice program will not be allowed to discharge the patient. The Medicare hospice benefit requires physicians to certify that their patients have six months or less to live before the patients are considered candidates for hospice care; under the new reimbursement policy, both the rights of patients to receive services and the financial stability of hospice programs will thus come to depend heavily on the accuracy of these prognostications by physicians. We wish to address three questions: What is the scientific accuracy of such prognostications? What can be learned from analogous circumstances in which physicians have been asked to make judgments for which there is no scientifically valid basis? and What is the best response from physicians to the current hospice problem?

Original languageEnglish (US)
Pages (from-to)920-922
Number of pages3
JournalNew England Journal of Medicine
Volume310
Issue number14
StatePublished - 1984
Externally publishedYes

Fingerprint

Hospice Care
Medicare
Hospices
Physicians
Terminally Ill
Patient Discharge
Patient Rights
Legislation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The physician's responsibility under the new medicare reimbursement for hospice care. / Brody, H.; Lynn, J.

In: New England Journal of Medicine, Vol. 310, No. 14, 1984, p. 920-922.

Research output: Contribution to journalArticle

@article{9686c810f9324bab890b03bb4d2dcc8f,
title = "The physician's responsibility under the new medicare reimbursement for hospice care",
abstract = "New legislation to provide Medicare reimbursement for hospice care has created problems for physicians who are involved in the treatment of the terminally ill. Under current proposals, hospice services will be reimbursed by a certain amount per patient-day, according to four categories of level of care, and for a maximum of 210 days. At 210 days, reimbursement will cease, but the hospice program will not be allowed to discharge the patient. The Medicare hospice benefit requires physicians to certify that their patients have six months or less to live before the patients are considered candidates for hospice care; under the new reimbursement policy, both the rights of patients to receive services and the financial stability of hospice programs will thus come to depend heavily on the accuracy of these prognostications by physicians. We wish to address three questions: What is the scientific accuracy of such prognostications? What can be learned from analogous circumstances in which physicians have been asked to make judgments for which there is no scientifically valid basis? and What is the best response from physicians to the current hospice problem?",
author = "H. Brody and J. Lynn",
year = "1984",
language = "English (US)",
volume = "310",
pages = "920--922",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "14",

}

TY - JOUR

T1 - The physician's responsibility under the new medicare reimbursement for hospice care

AU - Brody, H.

AU - Lynn, J.

PY - 1984

Y1 - 1984

N2 - New legislation to provide Medicare reimbursement for hospice care has created problems for physicians who are involved in the treatment of the terminally ill. Under current proposals, hospice services will be reimbursed by a certain amount per patient-day, according to four categories of level of care, and for a maximum of 210 days. At 210 days, reimbursement will cease, but the hospice program will not be allowed to discharge the patient. The Medicare hospice benefit requires physicians to certify that their patients have six months or less to live before the patients are considered candidates for hospice care; under the new reimbursement policy, both the rights of patients to receive services and the financial stability of hospice programs will thus come to depend heavily on the accuracy of these prognostications by physicians. We wish to address three questions: What is the scientific accuracy of such prognostications? What can be learned from analogous circumstances in which physicians have been asked to make judgments for which there is no scientifically valid basis? and What is the best response from physicians to the current hospice problem?

AB - New legislation to provide Medicare reimbursement for hospice care has created problems for physicians who are involved in the treatment of the terminally ill. Under current proposals, hospice services will be reimbursed by a certain amount per patient-day, according to four categories of level of care, and for a maximum of 210 days. At 210 days, reimbursement will cease, but the hospice program will not be allowed to discharge the patient. The Medicare hospice benefit requires physicians to certify that their patients have six months or less to live before the patients are considered candidates for hospice care; under the new reimbursement policy, both the rights of patients to receive services and the financial stability of hospice programs will thus come to depend heavily on the accuracy of these prognostications by physicians. We wish to address three questions: What is the scientific accuracy of such prognostications? What can be learned from analogous circumstances in which physicians have been asked to make judgments for which there is no scientifically valid basis? and What is the best response from physicians to the current hospice problem?

UR - http://www.scopus.com/inward/record.url?scp=0021327637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021327637&partnerID=8YFLogxK

M3 - Article

C2 - 6366559

AN - SCOPUS:0021327637

VL - 310

SP - 920

EP - 922

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 14

ER -